Dutch biotech Galapagos NV has agreed to buy the UK's Inpharmatica for €12.5 million in shares. Inpharmatica will become part of Galapagos' drug discovery services business, BioFocus DPI. Galapagos was also bullish about the acquisition's impact on its use of predictive modeling to pick drug targets.
- see this press release
- here's the AFX report on the acquisition deal